Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Double-blind, Randomized, Active Controlled, Parallel Group, Multicenter Phase II Clinical Trial to Evaluate the Effectiveness of X-22 as a Smoking Cessation Aid

NCT01400815 is registered in ClinicalTrials.gov with 22nd Century Limited, LLC as lead sponsor.

NCT NCT01400815
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01400815 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Double-blind, Randomized, Active Controlled, Parallel Group, Multicenter Phase II Clinical Trial to Evaluate the Effectiveness of X-22 as a Smoking Cessation Aid
Lead sponsor
22nd Century Limited, LLC
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2011
Completion date
December 31, 2012
Enrollment
234 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

smoking cessation